Nutriband Share Price (NASDAQ: NTRB)

$6.51

▲

-0.02

(-0.31%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Nutriband Stock chart to analyse performance

Nutriband stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$6.42
Today's High:$6.51
$6.51
1.38%
Downside
Day's Volatility :1.38%
Upside
0.0%
52 Weeks Low:$3.72
52 Weeks High:$11.78
$6.51
42.82%
Downside
52 Weeks Volatility :68.4%
Upside
44.74%

Nutriband Stock Returns

Period	Nutriband Inc	Index (Russel 2000)
3 Months	-20.84%	0.0%
6 Months	-6.69%	0.0%
1 Year	36.31%	0.0%
3 Years	70.07%	-4.1%

Nutriband Inc Key Stats

Check Nutriband key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$6.53
Open	$6.42
Today's High	$6.51
Today's Low	$6.42
Market Capitalization	$72.0M
Today's Volume	$7.4K
52 Week High	$11.78
52 Week Low	$3.7223
Revenue TTM	$2.4M
EBITDA	$-5.9M
Earnings Per Share (EPS)	$-0.9
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-108.02%

Stock Returns calculator for Nutriband Stock including INR - Dollar returns

The Nutriband stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Nutriband investment value today

Current value as on today

₹1,43,501

Returns

₹43,501

(+43.5%)

Returns from Nutriband Stock

₹38,217 (+38.22%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Nutriband Stock

-22%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Nutriband Stock from India on INDmoney has decreased by -22% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Nutriband Inc

Name
Holdings %
Name
Holdings %
Vanguard Group Inc
1.79%
Geode Capital Management, LLC
0.57%
State Street Corp
0.16%
Haven Private, LLC
0.10%
Northern Trust Corp
0.10%
Consolidated Portfolio Review Corp.
0.09%

Analyst Recommendation on Nutriband Stock

Rating

Trend

Buy

85%Buy

14%Hold

0%Sell

Based on 7 Wall street analysts offering stock ratings for Nutriband(by analysts ranked 0 to 5 stars)

Nutriband Share Price Target

What analysts predicted

Upside of 130.41%

Target:

$15.00

Current:

$6.51

Nutriband share price target is $15.00, a slight Upside of 130.41% compared to current price of $6.51 as per analysts' prediction.

Nutriband Stock Insights

Price Movement
In the last 1 month, NTRB stock has moved down by -11.0%
Increasing Revenue
Revenue is up for the last 2 quarters, 642.37K → 667.43K (in $), with an average increase of 3.8% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -5.51M → -1.38M (in $), with an average increase of 297.1% per quarter
NTRB vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 12.5%
NTRB vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.0% return, outperforming this stock by 49.2%
Price to Sales
ForNTRB every $1 of sales, investors are willing to pay $29.7, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.

Nutriband Inc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY20

FY21

FY22

FY23

FY24

FY25

	FY20	Y/Y Change
Revenue	$370.6K	↑ 51.11%
Net Income	$-2.8M	↓ 16.1%
Net Profit Margin	-754.1%	↑ 604.01%

	FY21	Y/Y Change
Revenue	$943.7K	↑ 154.61%
Net Income	$-3.2M	↑ 14.97%
Net Profit Margin	-340.52%	↑ 413.58%

	FY22	Y/Y Change
Revenue	$1.4M	↑ 50.7%
Net Income	$-8.4M	↑ 162.09%
Net Profit Margin	-592.23%	↓ 251.71%

	FY23	Y/Y Change
Revenue	$2.1M	↑ 46.23%
Net Income	$-4.8M	↓ 42.88%
Net Profit Margin	-231.33%	↑ 360.9%

	FY24	Y/Y Change
Revenue	$2.1M	↑ 0.27%
Net Income	$-5.5M	↑ 14.02%
Net Profit Margin	-263.04%	↓ 31.71%

	FY25	Y/Y Change
Revenue	$2.1M	↑ 2.62%
Net Income	$-10.5M	↑ 91.11%
Net Profit Margin	-489.86%	↓ 226.82%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$524.6K	↑ 22.62%
Net Income	$-1.9M	↑ 6.88%
Net Profit Margin	-358.54%	↑ 52.82%

	Q2 FY24	Q/Q Change
Revenue	$408.5K	↓ 22.13%
Net Income	$-1.9M	↑ 0.91%
Net Profit Margin	-464.61%	↓ 106.07%

	Q3 FY24	Q/Q Change
Revenue	$442.8K	↑ 8.4%
Net Income	$-1.7M	↓ 10.17%
Net Profit Margin	-385.02%	↑ 79.59%

	Q4 FY24	Q/Q Change
Revenue	$645.8K	↑ 45.83%
Net Income	$-1.4M	↓ 20.06%
Net Profit Margin	-211.06%	↑ 173.96%

	Q1 FY25	Q/Q Change
Revenue	$642.4K	↓ 0.53%
Net Income	$-5.5M	↑ 304.7%
Net Profit Margin	-858.68%	↓ 647.62%

	Q2 FY25	Q/Q Change
Revenue	$667.4K	↑ 3.9%
Net Income	$-1.4M	↓ 74.82%
Net Profit Margin	-208.11%	↑ 650.57%

FY20

FY21

FY22

FY23

FY24

FY25

	FY20	Y/Y Change
Profit	$-178.5K	↑ 314.87%

	FY21	Y/Y Change
Profit	$361.3K	↓ 302.47%

	FY22	Y/Y Change
Profit	$504.3K	↑ 39.57%

	FY23	Y/Y Change
Profit	$750.4K	↑ 48.8%

	FY24	Y/Y Change
Profit	$862.1K	↑ 14.88%

	FY25	Y/Y Change
Profit	$699.3K	↓ 18.88%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$181.2K	↑ 14.04%

	Q2 FY24	Q/Q Change
Profit	$154.2K	↓ 14.91%

	Q3 FY24	Q/Q Change
Profit	$90.8K	↓ 41.11%

	Q4 FY24	Q/Q Change
Profit	$179.6K	↑ 97.81%

	Q1 FY25	Q/Q Change
Profit	$274.6K	↑ 52.87%

	Q2 FY25	Q/Q Change
Profit	$243.5K	↓ 11.33%

FY20

FY21

FY22

FY23

FY24

FY25

	FY20	Y/Y Change
Operating Cash Flow	$-894.5K	↓ 19.09%
Investing Cash Flow	$67.0K	↓ 116.58%
Financing Cash Flow	$430.3K	↓ 78.31%

	FY21	Y/Y Change
Operating Cash Flow	$-297.1K	↓ 66.79%
Investing Cash Flow	$67.0K	↑ 0.0%
Financing Cash Flow	$371.9K	↓ 13.57%

	FY22	Y/Y Change
Operating Cash Flow	$-2.8M	↑ 845.69%
Investing Cash Flow	$-81.6K	↓ 221.79%
Financing Cash Flow	$7.6M	↑ 1951.96%

	FY23	Y/Y Change
Operating Cash Flow	$-3.0M	↑ 6.34%
Investing Cash Flow	$-79.3K	↓ 2.81%
Financing Cash Flow	$160.1K	↓ 97.9%

	FY24	Y/Y Change
Operating Cash Flow	$-3.5M	↑ 18.09%
Investing Cash Flow	$-51.8K	↓ 34.73%
Financing Cash Flow	$2.1M	↑ 1203.63%

	FY25	Y/Y Change
Operating Cash Flow	$-4.6M	↑ 31.17%
Investing Cash Flow	$-92.0K	↑ 77.82%
Financing Cash Flow	$8.5M	↑ 309.1%

Q2 FY24

Q3 FY24

Q4 FY24

Q2 FY25

	Q2 FY24	Q/Q Change
Operating Cash Flow	$-833.9K	↑ 16.11%
Investing Cash Flow	$-6.2K	-
Financing Cash Flow	$8.7M	↓ 173859.37%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$-1.5M	↑ 85.12%
Investing Cash Flow	$-38.9K	↑ 527.76%
Financing Cash Flow	$-5.1K	↓ 100.06%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$-1.0M	↓ 34.57%
Investing Cash Flow	$-47.0K	↑ 20.75%
Financing Cash Flow	$-5.2K	↑ 0.76%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$-1.3M	↑ 7.89%
Investing Cash Flow	$-5.3K	-
Financing Cash Flow	$-5.3K	↓ 96.38%

Nutriband Technicals Summary

Sell

Neutral

Buy

Nutriband is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Nutriband Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Nutriband Inc	-13.13%	-6.69%	36.31%	70.07%	11.96%
Regeneron Pharmaceuticals, Inc.	3.92%	-15.2%	-50.31%	-3.3%	-2.01%
Beone Medicines Ltd	2.49%	24.81%	62.78%	79.11%	29.69%
Vertex Pharmaceuticals Incorporated	-15.42%	-19.13%	-17.84%	34.68%	41.87%
Alnylam Pharmaceuticals, Inc.	11.08%	83.28%	75.87%	111.28%	242.25%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Nutriband Inc	NA	NA	NA	0.0	-1.08	-0.36	NA	0.46
Regeneron Pharmaceuticals, Inc.	14.6	14.6	1.2	39.42	0.15	0.07	0.0	287.55
Beone Medicines Ltd	NA	NA	NA	2.73	-0.05	-0.01	NA	34.32
Vertex Pharmaceuticals Incorporated	27.86	27.86	0.58	18.06	0.23	0.13	NA	67.02
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	3.92	-2.58	-0.03	NA	1.91

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Nutriband Inc	Buy	$72.0M	11.96%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$61.4B	-2.01%	14.6	31.37%
Beone Medicines Ltd	NA	$36.5B	29.69%	NA	-3.89%
Vertex Pharmaceuticals Incorporated	Buy	$100.5B	41.87%	27.86	31.86%
Alnylam Pharmaceuticals, Inc.	Buy	$59.5B	242.25%	NA	-12.96%

About Nutriband Inc

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops AVERSA buprenorphine and AVERSA methylphenidate, and other transdermal pharmaceutical products. The company has commercial development and clinical supply agreement with Kindeva Drug Delivery. The company was incorporated in 2016 and is headquartered in Orlando, Florida.

Organization	Nutriband
Employees	0
CEO	Mr. Gerald Goodman
Industry	Health Technology

Key Management of Nutriband Inc

Name	Title
Mr. Gerald Goodman	CFO & Chief Accounting Officer
Dr. Alan Smith Ph.D.	COO & President of 4P Therapeutics
Dr. Jeffrey Patrick Pharm.D.	Chief Scientific Officer
Mr. Michael Myer	President of Pocono Pharmaceutical
Mr. Tyler Overk	Head of Active Intelligence

Important FAQs about investing in NTRB Stock from India :

What is Nutriband share price today?

Nutriband share price today is $6.51 as on August 30, 2025 at 1:29 am IST at the close of the market. Nutriband share today touched a day high of $6.51 and a low of $6.42.

What is the 52 week high and 52 week low for Nutriband share?

Nutriband share touched a 52 week high of $11.78 and a 52 week low of $3.72. Nutriband stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $6.51, lower by 44.74% versus the 52 week high.

How to invest in Nutriband Stock (NTRB) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Nutriband on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Nutriband Shares that will get you 0.2304 shares as per Nutriband share price of $6.51 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Nutriband Stock (NTRB) from India?

Indian investors can start investing in Nutriband (NTRB) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Nutriband stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Nutriband share’s latest price of $6.51 as on August 30, 2025 at 1:29 am IST, you will get 1.5361 shares of Nutriband. Learn more about fractional shares .

What are the returns that Nutriband has given to Indian investors in the last 5 years?

Nutriband stock has given 11.96% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?